Patents by Inventor Charles E. Swindell

Charles E. Swindell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DHA-pharmaceutical agent conjugates of taxanes
    Patent number: 7199151
    Abstract: The invention provides conjugates of cis-docosahexaenoic acid and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided.
    Type: Grant
    Filed: July 14, 2003
    Date of Patent: April 3, 2007
    Assignee: Luitpold Pharmaceuticals, Inc.
    Inventors: Victor E. Shashoua, Charles E. Swindell, Nigel L. Webb, Matthews O. Bradley
  • DHA-pharmaceutical agent conjugates of taxanes
    Publication number: 20040180949
    Abstract: The invention provides conjugates of cis-docosahexaenoic acid and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided.
    Type: Application
    Filed: July 14, 2003
    Publication date: September 16, 2004
    Applicant: Protarga, Inc.
    Inventors: Victor E. Shashoua, Charles E. Swindell, Nigel L. Webb, Matthews O. Bradley
  • Dha-pharmaceutical agent conjugates to improve tissue selectivity
    Patent number: 6602902
    Abstract: The invention provides conjugates of cis-docosahexaenoic acid and pharmaceutical agents useful in treating noncentral nervous system conditions. Methods for selectively targeting pharmaceutical agents to desired tissues are provided.
    Type: Grant
    Filed: May 1, 2001
    Date of Patent: August 5, 2003
    Assignee: Protarga, Inc.
    Inventors: Victor E. Shashoua, Charles E. Swindell, Nigel L. Webb, Matthews O. Bradley